Stock evidence summary

XERS — Xeris Biopharma Holdings, Inc. - Common Stock

Indicator close (not current quote)
$6.95
Evidence score
46
Price/source label
indicator close — not current quote
Confidence
limited

Educational research only. ANNbroker is not a broker, dealer, investment adviser, or trading platform. Evidence summaries are not trade recommendations. Market data may be delayed, cached, incomplete, or inaccurate; use brokerage/exchange quotes for order entry. Options involve risk.

What could happen next

scenario, not forecast

XERS currently appears positive evidence with pullback risk based on available indicator evidence. This is a scenario summary, not a forecast; confidence is partial, limited.

Could happen

  • Price could continue showing positive pressure if trend, momentum, and volume evidence remain aligned.
  • A pullback could still happen if the move is extended, volume weakens, or price/source confidence changes.
  • ATR context suggests recent one-day movement has been around 3.75% ($0.26). That describes recent movement range, not future direction.

Supports

  • Price is above the 20-day moving average (6.40).
  • Price is above the 50-day moving average (6.25).
  • Supertrend state is bullish.
  • Parabolic SAR is below price, supporting the current upward structure.

Argues against

  • Price is below the 200-day moving average.
  • Price is 31.55% below its 52-week high.

Risks / confidence

  • Data trust note: only one OHLCV source verified for this cycle.
  • ATR risk is active at 3.75% of price.
  • Options activity is not confirmed in the starter universe; OptionsTransparencyAgent will mark contract-liquidity context as not confirmed unless an options-chain source is available.
  • Price/source confidence: indicator close — not current quote.
  • Indicator close is a research input for RSI/MACD/ATR/backtesting. It is not a live quote.
  • Current quote display is locked until fresh multi-source price checks pass. Use a brokerage/exchange quote for current price and order entry.
  • Confidence: partial, limited
  • Uses could/may/possible language. This is not a recommendation, prediction, or order-entry quote.

Indicator evidence

Positive / supportive evidence

  • Price is above the 20-day moving average (6.40).
  • Price is above the 50-day moving average (6.25).
  • Supertrend state is bullish.
  • Parabolic SAR is below price, supporting the current upward structure.
  • ADX/DMI shows a stronger upward trend: ADX 30.24, +DI 32.82 > -DI 10.30.
  • MACD histogram is positive (0.0750), showing upward momentum pressure.
  • RSI is constructive without being extreme (64.59).
  • 20-day rate of change is positive (16.55%).

Negative / opposing evidence

  • Price is below the 200-day moving average.
  • Price is 31.55% below its 52-week high.

Watchouts

Price/source confidence

Quote state
quote_locked
Label
indicator close — not current quote
ATR %
3.75%
1-day ATR context
$0.2589

Numbers table

Close6.9
Score46
Trend score18
Momentum score14
Volume/flow score20
Volatility/risk score-1
RSI 1464.5852
MACD histogram0.075
ADX 1430.236
ATR $0.2589
ATR %3.7528
1-day ATR low6.6411
1-day ATR high7.1589
Relative volume 200.9367
CMF 200.2235
Donchian position0.8583
Bollinger %B0.8775
Above VWAP 201

Weekly movement / options context

These are probability-readiness notes, not trade suggestions. Direction odds stay locked until Backtesting Agents validate a model for this symbol/timeframe.

1-week ATR range context
8.39%
Rise % over 1 week
pending validated direction model
Fall % over 1 week
pending validated direction model
Put/call odds
input-required

Open options probability sandbox Open backtesting notes

Backtesting status

Backtesting
background validation in progress
Public win-rate claims
locked until validated

Backtesting agents must validate indicator/timeframe win rates against historical data before the site displays them as measured results.

News/context

No stock-specific news context listed in the current public data.